ASPEN PHARMACARE HOLDINGS LIMITED - Director's Dealings

Director's Dealings

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")


DEALING IN SECURITIES BY DIRECTORS, COMPANY SECRETARY AND DIRECTORS OF A
MAJOR SUBSIDIARY

In compliance with paragraph 3.63 of the Listings Requirements of the JSE
Limited, disclosure is made of the following information:

DIRECTORS OF THE COMPANY

Director                       :   Stephen Bradley Saad
Date of transaction            :   1 November 2012
Nature of transaction          :   Acceptance of deferred incentive
                                   bonus shares (vesting after three
                                   years)
Number of securities           :   15 518
Class of securities            :   Ordinary shares
Grant price                    :   R156.00
Value of Transaction           :   R2 420 808
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes

Director                       :   Michael Guy Attridge
Date of transaction            :   1 November 2012
Nature of transaction          :   Acceptance of deferred incentive
                                   bonus shares (vesting after three
                                   years)
Number of securities           :   12 829
Class of securities            :   Ordinary shares
Grant price                    :   R156.00
Value of Transaction           :   R2 001 324
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes


COMPANY SECRETARY OF THE COMPANY

Company Secretary              :   Riaan Verster
Date of transaction            :   1 November 2012
Nature of transaction          :   Acceptance of deferred incentive
                                   bonus shares (vesting after three
                                   years)
Number of securities           :   1 745
Class of securities            :   Ordinary shares
Grant price                    :   R156.00
Value of Transaction           :   R272 220
Nature of interest             :   Direct beneficial
Clearance obtained             :   Yes


DIRECTORS OF A MAJOR SUBSIDIARY

Director                          :   Sean Capazorio
Subsidiary Company                :   Pharmacare Limited
Date of transaction               :   1 November 2012
Nature of transaction             :   Acceptance of deferred incentive
                                      bonus shares (vesting after three
                                      years)
Number of securities              :   4 582
Class of securities               :   Ordinary shares
Grant price                       :   R156.00
Value of Transaction              :   R714 792
Nature of interest                :   Direct beneficial
Clearance obtained                :   Yes

Director                          :   Morne Geyser
Subsidiary Company                :   Pharmacare Limited
Date of transaction               :   1 November 2012
Nature of transaction             :   Acceptance of deferred incentive
                                      bonus shares (vesting after three
                                      years)
Number of securities              :   4 391
Class of securities               :   Ordinary shares
Grant price                       :   R156.00
Value of Transaction              :   R684 996
Nature of interest                :   Direct beneficial
Clearance obtained                :   Yes

Director                          :   Noel Guliwe
Subsidiary Company                :   Pharmacare Limited
Date of transaction               :   1 November 2012
Nature of transaction             :   Acceptance of deferred incentive
                                      bonus shares (vesting after three
                                      years)
Number of securities              :   3 894
Class of securities               :   Ordinary shares
Grant price                       :   R156.00
Value of Transaction              :   R607 464
Nature of interest                :   Direct beneficial
Clearance obtained                :   Yes

All acceptances of deferred bonus shares are deemed to be off-market
trades.

Durban
2 November 2012

Sponsor
Investec Bank Limited

Date: 02/11/2012 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.